Post by Ardigen

There’s a lot happening in AI drug discovery, but not everything makes it into the headlines - so Ardigen Bulletin brings together event insights, research, and industry updates. In #1: - Conference takeaways from AACR, PEGS, Bio-IT World, and SLAS Europe - A closer look at the infrastructure gap in image-based profiling - The FDA’s latest steps toward real-time, AI-supported regulatory workflows Plus: AI adoption in pharma and selected Ardigen articles, podcast episodes, and webinars. Read the first edition below and subscribe for monthly AI drug discovery insights. #AIDrugDiscovery #DrugDiscovery #Biotech #Pharma #LifeSciences #ComputationalBiology #ClinicalTrials #ImageBasedProfiling #Bioinformatics